The Mucolipidosis Type IV (ML4) Foundation funds, supports, and promotes medical and scientific research dedicated finding treatments for this rare, autosomal, lysosomal disease. Children with ML4 experience severe neurological complications from this disease, including significant psychomotor developmental delays, as well as blindness. In addition to continuing to explore basic mechanisms of the disease, the ML4 Foundation supports research in small molecule discovery, gene therapy, and clinical research.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Ml4 Foundation, 3500 Piedmont Road,
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.ml4.org
- Keywords
- Lysosomal disease, Neurological disease, Translational science, Patient advocacy, Natural history.
- HQ
- Atlanta, GA
- Competitors
- Atlanta Public Schools.
Mucolipidosis Type Iv (Ml4) Foundation Questions
Mucolipidosis Type Iv (Ml4) Foundation's website is http://www.ml4.org
Mucolipidosis Type Iv (Ml4) Foundation's LinkedIn profile is https://www.linkedin.com/company/mucolipidosis-type-iv-ml4-foundation
Mucolipidosis Type Iv (Ml4) Foundation has
3 employees.
View email and phone details for 3
employees at Mucolipidosis Type Iv (Ml4) Foundation.
Mucolipidosis Type Iv (Ml4) Foundation's industry is
Research Services
Mucolipidosis Type Iv (Ml4) Foundation's top competitors are
Atlanta Public Schools.
Mucolipidosis Type Iv (Ml4) Foundation's categories are Research Services
Mucolipidosis Type Iv (Ml4) Foundation's founding year is 1982
